Human NK cells constitutively express membrane TNF-α (mTNFα) and present mTNFα-dependent cytotoxic activity

European Journal of Immunology

Volumn 29, Issue 11, 1999, Pages 3588-3595

  Caron, Gersende ^a   Delneste, Yves ^a   Aubry, Jean Pierre ^a   Magistrelli, Giovanni ^a   Herbault, Nathalie ^a   Blaecke, Aline ^a   Meager, Anthony ^b   Bonnefoy, Jean Yves ^a   Jeannin, Pascale ^a,c  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c Centre d'Immunologie Pierre Fabre   (France)

Author keywords

Cytotoxicity; Human NK cell; Membrane TNF ; Tumoral cell

Indexed keywords

FAS LIGAND; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; MEMBRANE PROTEIN; MESSENGER RNA; PARAFORMALDEHYDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 0032723672     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199911)29:11<3588::AID-IMMU3588>3.0.CO;2-O     Document Type: Article

References (45)

1. Bazzoni, F. and Beutler, B., The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 1996. 334: 1717-1725.
2. Kriegler, M., Perez, C., DeFay, K., Albert, I. and Lu, S. D., A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988. 53: 45-53.
3. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., Kronheim, S. R., Petersen, M., Gerhart, M., Kozlosky, C. J., March, C. J. and Black, R. A., Protection against lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 1984. 370: 218-220.
4. Adolf, G. A., Grell, M. and Scheurich, P., Tumor necrosis factor. In Luger, T. A. and Schwarz, T. (Eds.) Epidermal Growth Factors and Cytokines. Marcel Dekker Inc., New York 1993. p 63.
5. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995. 377: 348-351.
6. Braun, M. Y., Lowin, B., French, L., Acha-Orbea, H. and Tschopp, J., Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 1996. 183: 657-661.
7. Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L. and Kriegler, M., A nonsecretabte cell surface mutant of tumor necrosis factor (TNF) kill by cell-to-cell contact. Cell 1990. 63: 251-258.
8. Grell, M., Douani, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, B., Lesslauer, W., Kollias, G., Pfizenmaier, K. and Scheurich, P., The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995. 83: 793-802.
9. Decker, T., Lohmann-Matthes, M. L. and Gifford, G. E., Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 1987. 138: 957-962.
10. Kinkhabwala, M., Sehajpal, P., Skolnik, E., Smith, D., Sharma, V. K., Vlassara, H., Cerami, A. and Suthanthiran, M., A novel addition to the T cell repertoire. Cell surface expression of tumor necrosis factor/cachexin by activated normal human T cells. J. Exp. Med. 1990. 171: 941-946.
11. Ratner, A. and Clark, W. R., Role of TNFα in CD8+ cytotoxic T lymphocyte-mediated lysis. J. Immunol. 1993. 150: 4303-4314.
12. Trinchieri, G., Biology of natural killer cells. Adv. Immunol. 1989. 47: 187-376.
13. Scott, P. and Trinchieri, G., The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 1995. 7: 34-40.
14. Biron, C. A., Activation and function of natural killer cell responses during viral infections. Curr. Opin. Biol. 1997. 9: 24-34.
15. Berke, G., Killing mechanisms of cytotoxic lymphocytes. Curr. Opin. Hematol. 1997. 4: 32-40.
16. Moretta, A., Molecular mechanisms in cell-mediated cytotoxicity. Cell 1997. 90: 13-18.
17. Paya, C. V., Kenmotsu, N., Schoon, R. A. and Leibson, P. J., Tumor necrosis factor and lymphotoxin-secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 1988. 141: 1989-1995.
18. Arase, H., Arase, N. and Saito, T., Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 1995. 181: 1235-1238.
19. Carbone, E., Ruggiero, G., Terrazzano, G., Palombe, C., Manzo, C., Fontana, S., Spits, H., Karre, K. and Zappacosta, S., A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 1997. 185: 2053-2060.
20. Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S. and Perussia, B., Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 1998. 188: 2375-2380.
21. Montel, A. H., Bocham, M. R., Hobbs, J. A., Lynch, D. H. and Brahmi, Z., Fas involvement in cytotoxicity mediated by human natural killer cells. Cell. Immunol. 1995. 166: 236-246.
22. Eischen, C. M., Schilling, J. D., Lynch, D. H., Krammer, P. H. and Leibson, P. J., Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 1996. 156: 2693-2699.
23. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata, S., Fas ligand in human serum. Nat. Med. 1996. 2: 317-322.
24. Medvedev, A. E., Johnsen, A. C., Haux, J., Steinkjer, B., Egeberg, K., Lynch, D., Sundan, A. and Epsevik, T., Regulation of Fas and Fas ligand expression in NK cells by cytokines and the involvement of Fas ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 1997. 9: 394-404.
25. Vujanovic, N. L., Nagashima, S., Herberman, R. B. and Whiteside, T. L., Nonsecretory apoptotic killing by human NK cells. J. Immunol. 1996. 157: 1117-1126.
26. Oshimi, Y., Oda, S., Honda, Y., Nagata, S. and Miyazaki, S., Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 1996. 157: 2909-2915.
27. Ware, C. F., Crowe, P. D., Grayson, M. H., Androlewicz, M. J. and Browning, J. L., Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 1992. 149: 3881-3888.
28. + T cells. J. Exp. Med. 1997. 186: 1407-1418.
29. Mason, A. T., Mc Vicar, D. W., Smith, C. A., Young, H. A., Ware, C. F. and Ortaldo, J. R., Regulation of NK cells through the 80-kDa TNFR (CD120b). J. Leukoc. Biol. 1995. 58: 249-255.
30. Kumagai, K., Abo, T., Sekizawa, T. and Sasaki, M., Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 °C. J. Immunol. 1975. 115: 982-987.
31. Henney, C. S., Kuribayashi, K., Kern, O. E. and Gillis, S., Interleukin-2 augments natural killer cell activity. Nature 1981. 291: 335-338.
32. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B. and Trinchieri, G., Identification and purification of natural killer cells stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 1989. 170: 827-845.
33. + NK cells. J. Immunol. 1992. 148: 2429-2436.
34. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenman, J., Grabstein, K. and Galigiuri, M. A., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994. 180: 1395-1403.
35. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K. and Akira, S., Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998. 8: 383-390.
36. Delneste, Y., Jeannin, P., Potier, L., Romero, P. and Bonnefoy, J. Y., N-Acetyl-L-Cysteine exhibits antitumoral activity by increasing tumor necrosis factor a-dependent T-cell cytotoxicity. Blood 1997. 90: 1124-1132.
37. Jewett, A., Gan, X.-H., Lebow, L. T. and Bonavida, B., Differential secretion of TNFα and IFNγ by human peripheral blood-derived NK subsets and association with functional maturation. J. Clin. Immunol. 1996. 16: 46-54.
38. Salvucci, O., Mami-Chouabi, F., Moreau, J. L., Thèze, J., Chehimi, J. and Chouaib, S., Differential regulation of interleukin-2 and interleukin-15-induced natural killer cell activation by interleukin-4. Eur. J. Immunol. 1996. 26: 2736-2741.
39. Puren, A. J., Fantuzzi, G., Gu, Y., Su, M. S. and Dinarello, C. A., Interleukin-18 (IFNγ-inducing factor) induces IL-18 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 1998. 101: 711-721.
40. Meager, A., Sampson, L. E., Grell, M. and Sheurich, P., Development of resistance to tumor necrosis factor (TNFα) in KYM-1 cells involves both TNF receptors. Cytokine 1993. 5: 556-563.
41. Grell, M., Krammer, P. H. and Sheurich, P., Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis. Eur. J. Immunol. 1994. 24: 2563-2566.
42. Dao, T., Mahal, W. Z. and Crispe, I. N., IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 1998. 161: 2217-2222.
43. Allen, M. P. and Nilsen-Hamilton, M., Granzymes D, E, F, and G are regulated through pregnancy and by IL-2 and IL-15 in granulated metrial gland cells. J. Immunol. 1998. 161: 2772-2779.
44. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y. and Kaneda, K., IFNγ-inducing factor up-regulated Fas-ligand mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 1996. 157: 3967-3973.
45. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C. and Moretta, L., Major histocompatibility complex class-I specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 1997. 155: 105-117.